Charles River Laboratories International Overview
Charles River Laboratories International Target Price
Analysts' average 12-month price target for Charles River Laboratories International is $250.
Get informed when a big investor buys or sells
+ FollowShare Price
$288.5
Average Target Price
$250.69
13.1% downside
13.1% downside16 analysts in the last 4 months
High: $300 | Low: $192
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-10 | Piper Sandler | $300 |  4% upside |  |
| 2026-08-10 | Mizuho Securities | $264 | 8.5% downside | |
| 2026-08-07 | Morgan Stanley | $300 | 4% upside | |
| 2026-08-06 | Robert W. Baird | $291 | 0.9% upside | |
| 2026-08-06 | RBC Capital | $282 | 2.3% downside | |
| 2026-08-05 | Barclays | $300 | 4% upside | |
| 2026-07-13 | Mizuho Securities | $230 | 20.3% downside | |
| 2026-07-09 | Morgan Stanley | $260 | 9.9% downside | |
| 2026-07-01 | BNP Paribas | $250 | 13.3% downside | |
| 2026-07-01 | Bernstein | $250 | 13.3% downside | |
| 2026-06-17 | Morgan Stanley | $220 | 23.7% downside | |
| 2026-05-29 | CLSA | $219 | 24.1% downside | |
| 2026-05-08 | Robert W. BairdEric Coldwell | $213 | 26.2% downside | |
| 2026-05-08 | Evercore ISI | $220 | 23.7% downside | |
| 2026-05-08 | Mizuho Securities | $192 | 33.4% downside | |
| 2026-05-08 | BarclaysLuke Sergott | $220 | 23.7% downside | |
| 2026-04-14 | BarclaysLuke Sergott | $210 | 27.2% downside | |
| 2026-04-14 | RBC Capital | $215 | 25.5% downside | |
| 2026-02-20 | Mizuho Securities | $175 | 39.3% downside | |
| 2026-02-19 | Robert W. BairdEric Coldwell | $193 | 33.1% downside | |
| 2026-02-19 | BarclaysLuke Sergott | $200 | 30.7% downside | |
| 2026-01-13 | Robert W. Baird | $231 | 19.9% downside | |
| 2026-01-13 | Evercore ISI | $260 | 9.9% downside | |
| 2026-01-09 | Robert W. BairdEric Coldwell | $224 | 22.4% downside | |
| 2026-01-09 | Mizuho SecuritiesAnn Hynes | $215 | 25.5% downside | |
| 2025-12-18 | Mizuho Securities | $200 | 30.7% downside | |
| 2025-12-15 | Barclays | $215 | 25.5% downside | |
| 2025-12-01 | Morgan StanleyKallum Titchmarsh | $185 | 35.9% downside | |
| 2025-11-17 | Argus Research | $200 | 30.7% downside | |
| 2025-10-17 | Mizuho SecuritiesAnn Hynes | $174 | 39.7% downside | |
| 2025-10-03 | Evercore ISIElizabeth Anderson | $200 | 30.7% downside | |
| 2025-10-02 | BarclaysLuke Sergott | $195 | 32.4% downside | |
| 2025-09-09 | Jefferies | $195 | 32.4% downside | |
| 2024-10-15 | BarclaysLuke Sergott | $205 | 28.9% downside | |
| 2024-10-14 | Redburn PartnersJamie Clark | $151 | 47.7% downside | |
| 2024-09-17 | Mizuho SecuritiesAnn Hynes | $210 | 27.2% downside | |
| 2024-08-08 | Deutsche BankJustin Bowers | $240 | 16.8% downside | |
| 2024-07-10 | Robert W. BairdEric Coldwell | $239 | 17.2% downside | |
| 2024-06-28 | BarclaysLuke Sergott | $230 | 20.3% downside | |
| 2024-06-06 | Goldman SachsMatthew Sykes | $290 | 0.5% upside | |
| 2024-05-09 | Evercore ISIElizabeth Anderson | $265 | 8.1% downside | |
| 2024-04-01 | Evercore ISIElizabeth Anderson | $300 | 4% upside | |
| 2022-05-05 | KeyBancDonald Hooker | $300 | 4% upside | |
| 2022-04-25 | Wells Fargo | $325 | 12.7% upside | |
| 2022-04-25 | JefferiesDavid Windley | $280 | 2.9% downside | |
| 2022-01-11 | JefferiesDavid Windley | $464 | 60.8% upside | |
| 2021-11-24 | Argus ResearchDavid Toung | $440 | 52.5% upside | |
| 2021-08-17 | Cowen & Co.Daniel Brennan | $465 | 61.2% upside | |
| 2021-08-04 | Credit SuisseKatie Tryhane | $385 | 33.4% upside | |
| 2021-05-28 | J.P. MorganTycho Peterson | $390 | 35.2% upside | |